BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 23413211)

  • 1. Successful percutaneous transcatheter patent foramen ovale closure through the right internal jugular vein using a steerable catheter.
    Hascoet S; Fraisse A; Elbaz M
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E598-602. PubMed ID: 23413211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Percutaneous Transcatheter Patent Foramen Ovale Closure Through The Right Internal Jugular Vein Using Stiff Amplatzer Catheter With A Reshaped Tip.
    Fanari Z; Hammami S; Hopkins JT
    Del Med J; 2016 Aug; 88(8):238-241. PubMed ID: 28751787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
    Spies C; Khandelwal A; Timmemanns I; Kavinsky CJ; Schräder R; Hijazi ZM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):966-70. PubMed ID: 18942060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transhepatic approach to closure of patent foramen ovale: report of 2 cases in adults.
    Hussain J; Strumpf R; Ghandforoush A; Jamal A; Diethrich E
    Tex Heart Inst J; 2010; 37(5):553-6. PubMed ID: 20978566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of Transcatheter Closure of Patent Foramen Ovale.
    Neill J; Lin CH
    Methodist Debakey Cardiovasc J; 2017; 13(3):152-159. PubMed ID: 29744000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study.
    Rigatelli G; Dell'avvocata F; Braggion G; Giordan M; Chinaglia M; Cardaioli P
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):973-6. PubMed ID: 19021284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderly.
    Takafuji H; Hosokawa S; Ogura R; Hiasa Y
    Heart Vessels; 2019 Oct; 34(10):1657-1662. PubMed ID: 30868214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interventional closure of persistent foramen ovale in patients after crytogenic stroke].
    Chatterjee T; Akin I; Nienaber CA; Rehders TC; Ortak J; Chatterjee A; Ince H
    Praxis (Bern 1994); 2010 Oct; 99(20):1203-15. PubMed ID: 20931496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
    Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
    JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantation of a Occlutech Figulla PFO occluder in a patient with patent foramen ovale and history of embolic stroke.
    Krecki R; Peruga JZ; Plewka M; Krzemińska-Pakuła M; Kasprzak JD
    Cardiol J; 2008; 15(4):380-2. PubMed ID: 18698549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
    Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent events after percutaneous closure of patent foramen ovale.
    Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premere occlusion system for transcatheter patent foramen ovale closure: mid-term results of a single-center registry.
    Rigatelli G; Cardaioli P; Dell'avvocata F; Giordan M; Chinaglia M
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):564-9. PubMed ID: 20602480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.